Identifying MASLD patient eligibility for pharmacological therapy: the need to integrate evidence into clinical practice

J.A. is funded by the Spanish Ministry of Economy, Innovation and Competition, Instituto de Salud Carlos III (PI22/01345, PI25/01825, FORT23/00008 and GLD24/25635) and co-funded by the European Union. The funders have not had any role in the design, analysis, writing or interpretation of this project.

Comments (0)

No login
gif